
Ekroz Tablet
Marketer
Evaxo Pharma
Salt Composition
Rabeprazole (20mg)
Overview Ekroz Tablet
Acid-reducing medication, Acidex, lessens stomach acid production. It treats stomach and intestinal conditions like acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, offering symptom relief and promoting healing. Acidex should be taken once daily, ideally an hour before breakfast. Dosage depends on your condition and response; consistent daily timing is crucial, even if symptoms subside rapidly. Dietary modifications, such as smaller, more frequent meals, and avoiding caffeine, spicy foods, and fatty foods, may also help manage symptoms. Common, usually mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, and stomach ache. Persistent or bothersome side effects warrant medical attention. Prolonged use (over a year), especially at higher doses, increases fracture risk; discuss bone health strategies, such as calcium and vitamin D supplementation, with your doctor. Low magnesium (hypomagnesemia) can occur after three months; symptoms include fatigue, confusion, dizziness, muscle spasms, and irregular heartbeat. Your doctor may monitor your magnesium levels. Acidex isn't for everyone; inform your physician of severe liver disease, HIV medication use, prior allergic reactions to similar drugs, osteoporosis, or pregnancy/breastfeeding before starting treatment. Alcohol should be avoided due to its acid-stimulating properties. Refrain from operating machinery if dizziness or drowsiness occurs.
Primary Ingredients of Ekroz Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Ekroz Tablet
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Ekroz Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Ekroz Tablet on an empty stomach.
Common Side effects of Ekroz Tablet:
- Diarrhea
- Dizziness
- Flatulence
- Headache
- Nausea
- Sore throat
- Stomach pain
- Vomiting
How to use Ekroz Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Ekroz Tablet on an empty stomach.
How Ekroz Tablet works:
Stomach acid is neutralized by Ekroz Tablet, a proton pump inhibitor (PPI), providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Ekroz Tablet concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Ekroz Tablet during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data suggest potential risk associated with Ekroz Tablet use while breastfeeding. Limited evidence indicates the drug might transfer to breast milk, potentially harming the infant.
DrivingUNSAFE
Taking Ekroz Tablets may cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these side effects are experienced.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely take Ekroz Tablets without requiring any modification to the prescribed dosage.
LiverSAFE IF PRESCRIBED
Ekroz Tablet poses no known safety concerns for patients with hepatic impairment, and no alteration of the prescribed dosage is necessary.
What if you forget to take Ekroz Tablet :
Should you forget to take your Ekroz Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ekroz Tablet
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Behavioral Class | PPIs |
